These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The significance of a new radiopharmaceutic agent, 99mTc-mercaptoacetyltriglycine (MAG 3), in the diagnosis of diseases of the kidneys and urinary tract in children]. Lepej J; Svitác J; Kliment J; Buchanec J; Marosová A; Altmann P; Horák V; Holan J Cesk Pediatr; 1990 Mar; 45(3):134-7. PubMed ID: 2149306 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders. Müller-Suur R; Bois-Svensson I; Mesko L J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371 [TBL] [Abstract][Full Text] [Related]
4. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA]. Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424 [TBL] [Abstract][Full Text] [Related]
9. Uterine technetium-99m mercaptoacetyltriglycine and diethylene triamine penta-acetic acid uptake in the scintigraphic evaluation of transplanted kidneys. Erbas B; Arinsoy T; Ugur O; Varoglu E; Arik N; Bekdik CF Eur J Nucl Med; 1992; 19(5):375-7. PubMed ID: 1535316 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of technetium-99m-MAG3 in humans. Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528 [TBL] [Abstract][Full Text] [Related]
11. Can technetium-99m-mercaptoacetyltriglycine replace technetium-99m-dimercaptosuccinic acid in the exclusion of a focal renal defect? Gordon I; Anderson PJ; Lythgoe MF; Orton M J Nucl Med; 1992 Dec; 33(12):2090-3. PubMed ID: 1334134 [TBL] [Abstract][Full Text] [Related]
12. 99mTc renal tubular function agents: current status. Eshima D; Fritzberg AR; Taylor A Semin Nucl Med; 1990 Jan; 20(1):28-40. PubMed ID: 2136959 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of renal scintigraphy and clearance with 99mTc-MAG3 and 123I-hippurate in patients with renal disorders. Müller-Suur R; Bois-Svensson I; Mesko L Contrib Nephrol; 1990; 79():32-5. PubMed ID: 2146087 [No Abstract] [Full Text] [Related]
14. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys]. Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251 [TBL] [Abstract][Full Text] [Related]
15. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine. Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function. Taylor A; Ziffer JA; Eshima D Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307 [TBL] [Abstract][Full Text] [Related]
18. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate. Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350 [TBL] [Abstract][Full Text] [Related]
19. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples. Russell CD; Taylor A; Eshima D J Nucl Med; 1989 Dec; 30(12):1955-9. PubMed ID: 2531219 [TBL] [Abstract][Full Text] [Related]
20. Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties. Vanbilloen HP; De Roo MJ; Verbruggen AM Eur J Nucl Med; 1996 Jan; 23(1):40-8. PubMed ID: 8586100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]